{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:59:27Z","timestamp":1792799967140,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":3939,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.jpainsymman.2008.03.018","type":"journal-article","created":{"date-parts":[[2008,9,18]],"date-time":"2008-09-18T12:15:00Z","timestamp":1221740100000},"page":"698-708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["An Intravenous Ketamine Test as a Predictive Response Tool in Opioid-Exposed Patients with Persistent Pain"],"prefix":"10.1016","volume":"37","author":[{"given":"Steven P.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geselle","family":"McKnight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Marcuson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianren","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2008.03.018_bib1","first-page":"645","article-title":"Using oral medications, infusions and injections for differential diagnosis of orofacial pain","volume":"34","author":"Ram","year":"2006","journal-title":"J Calif Dent Assoc"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1747-4477.2000.tb00270.x","article-title":"Neuropathic orofacial pain. Part 2\u2014diagnostic procedures, treatment guidelines and case reports","volume":"26","author":"Vickers","year":"2000","journal-title":"Aust Endod J"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3959(91)90028-V","article-title":"Intravenous phentolamine test: diagnostic and prognostic use in reflex sympathetic dystrophy","volume":"46","author":"Arner","year":"1991","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib4","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1212\/WNL.43.6.1233","article-title":"Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury","volume":"43","author":"Galer","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.7326\/0003-4819-140-8-200404200-00010","article-title":"Pain: moving from symptom control toward mechanism-specific pharmacologic management","volume":"140","author":"Woolf","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib6","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archneur.60.11.1524","article-title":"Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations","volume":"60","author":"Dworkin","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejpain.2004.05.006","article-title":"Intravenous opioid testing in patients with chronic non-cancer pain","author":"Gustorff","year":"2005","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1212\/WNL.58.4.554","article-title":"Effects of IV morphine in central pain: a randomized placebo-controlled study","volume":"58","author":"Attal","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib9","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3171\/foc.2001.11.3.2","article-title":"Motor cortex stimulation for deafferentation pain","volume":"11","author":"Saitoh","year":"2001","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-3-211-33081-4_3","article-title":"Extradural cortical stimulation for central pain","volume":"97","author":"Canavero","year":"2007","journal-title":"Acta Neurochir Suppl"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jpain.2005.12.010","article-title":"The IV ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients","volume":"7","author":"Cohen","year":"2006","journal-title":"J Pain"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0885-3924(96)00126-1","article-title":"Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective study","volume":"12","author":"Galer","year":"1996","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib13","first-page":"157","article-title":"The predictive lidocaine test in treatment of neuropathic pain","volume":"66","author":"Trentin","year":"2000","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib14","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1213\/01.ANE.0000136953.11583.7B","article-title":"The IV ketamine test: a predictive response tool for an oral dextromethorphan treatment regimen in neuropathic pain","volume":"99","author":"Cohen","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib15","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00296-007-0403-9","article-title":"The classification of fibromyalgia syndrome","volume":"27","author":"Muller","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib16","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S1388-2457(00)00267-4","article-title":"Motor cortical dysfunction disclosed by single and double magnetic stimulation in patients with fibromyalgia","volume":"111","author":"Salerno","year":"2000","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0304-3959(99)00308-5","article-title":"Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients","volume":"85","author":"Graven-Nielsen","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib18","first-page":"1615","article-title":"Fibromyalgia\u2014are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs","volume":"24","author":"Sorenson","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0304-3959(00)00432-2","article-title":"Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome","volume":"91","author":"Staud","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-2999(01)01307-3","article-title":"NMDA receptors as targets for drug action in neuropathic pain","volume":"429","author":"Parsons","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11916-003-0009-1","article-title":"N-methyl-D-aspartate-enhanced analgesia","volume":"7","author":"Hewitt","year":"2003","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-201X.1996.566309000.x","article-title":"N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat","volume":"158","author":"Grass","year":"1996","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib23","first-page":"825","article-title":"Comparison of ketamine and dextromethorphan in potentiating the antinociceptive effect of morphine in rats","volume":"86","author":"Plesan","year":"1998","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0304-3959(94)90022-1","article-title":"Dextromethorphan attenuates and reverses analgesic tolerance to morphine","volume":"59","author":"Elliott","year":"1994","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0006-8993(94)91538-5","article-title":"Inhibition of opiate tolerance by non-competitive n-methyl-d-aspartate receptor antagonists","volume":"633","author":"Trujillo","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib26","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0885-3924(99)00128-1","article-title":"Morphidex pharmacokinetic studies and single-dose analgesic efficacy studies in patients with postoperative pain","volume":"19","author":"Caruso","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib27","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0885-3924(99)00130-X","article-title":"Morphine with dextromethorphan: conversion from other opioid analgesics","volume":"19","author":"Chevlen","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib28","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0885-3924(99)00129-3","article-title":"Morphidex (MS:DM) double-blind, multiple-dose studies in chronic pain patients","volume":"19","author":"Katz","year":"2000","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.pain.2005.03.004","article-title":"Morphidex (morphine sulfate\/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance","volume":"115","author":"Galer","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jpainsymman.2006.09.017","article-title":"A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients","volume":"33","author":"Dudgeon","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib31","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.20828","article-title":"Randomized, controlled trial of dextromethorphan\/quinidine for pseudobulbar affect in multiple sclerosis","volume":"59","author":"Panitch","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.0001-5172.2004.0325.x","article-title":"Analgesic effect of dextromethorphan in neuropathic pain","volume":"48","author":"Carlsson","year":"2004","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib33","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1245\/ASO.2003.08.007","article-title":"Dextromethorphan mitigates phantom pain in cancer amputees","volume":"10","author":"Ben Abraham","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib34","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/00000542-200205000-00005","article-title":"Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials","volume":"96","author":"Sang","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0304-3959(01)00455-9","article-title":"Analgesic effects of dextromethorphan and morphine in patients with chronic pain","volume":"96","author":"Heiskanen","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib36","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1212\/WNL.55.7.964","article-title":"A randomized, controlled trial of high-dose dextromethorphan in facial neuralgias","volume":"55","author":"Gilron","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib37","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1212\/WNL.48.5.1212","article-title":"High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia","volume":"48","author":"Nelson","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0304-3959(94)90056-6","article-title":"Dextromethorphan for the treatment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-1 design","volume":"59","author":"McQuay","year":"1994","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib39","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/BF03017431","article-title":"Short- and long-term efficacy of oral ketamine in eight chronic-pain patients","volume":"49","author":"Furuhashi-Yonaha","year":"2002","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0304-3959(99)00117-7","article-title":"N of 1 randomised controlled trials of oral ketamine in patients with chronic pain","volume":"83","author":"Haines","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib41","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/00000542-199906000-00005","article-title":"Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management","volume":"90","author":"Lauretti","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(93)91368-3","article-title":"Intrathecal treatment with dextrorphan and ketamine potently reduce pain-related behaviors in a rat model of painful peripheral mononeuropathy","volume":"605","author":"Mao","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib43","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1200\/JCO.2000.18.8.1780","article-title":"Drug interactions in palliative care","volume":"18","author":"Bernard","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/00002018-199819030-00002","article-title":"Adverse effects of opioid agonists and agonist-antagonists in anaesthesia","volume":"19","author":"Bowdle","year":"1998","journal-title":"Drug Saf"},{"issue":"3","key":"10.1016\/j.jpainsymman.2008.03.018_bib45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/rapm-00115550-200805000-00002","article-title":"The effect of opioid dose and treatment duration on the perception of a painful standardized clinical stimulus","volume":"33","author":"Cohen","year":"2008","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib46","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coph.2004.08.012","article-title":"Opioids: cellular mechanisms of tolerance and physical dependence","volume":"5","author":"Bailey","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/bip.20254","article-title":"Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure","volume":"80","author":"Ossipov","year":"2005","journal-title":"Biopolymers"},{"key":"10.1016\/j.jpainsymman.2008.03.018_bib48","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0885-3924(00)00228-1","article-title":"Opioid poorly-responsive cancer pain. Part 1: clinical considerations","volume":"21","author":"Mercadente","year":"2001","journal-title":"J Pain Symptom Manage"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539240800434X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539240800434X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:01:00Z","timestamp":1760130060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088539240800434X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S088539240800434X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2008.03.018","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Intravenous Ketamine Test as a Predictive Response Tool in Opioid-Exposed Patients with Persistent Pain","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2008.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}